[Epidemiological surveillance: review of data from the Febrile Unit of the Muñiz Hospital 2020-2024].

The appearance of epidemiological events that threaten the health system marked the importance of responses that go beyond the dissemination of information and since the COVID-19 pandemic, the Government of the City of Buenos Aires (Argentina) proposed an epidemiological surveillance model in devices called Febrile Units (UF). At the Muñiz Hospital, this unit provided epidemiological surveillance strategies in the pandemic and the different epidemics and outbreaks, still continuing its operation today. The objective of this work is to evaluate the implementation of the Febril Unit as an epidemiological surveillance structure.

Development and Characterization of Film-Forming Solution Loaded with (L.) Skeels for Topical Application in Post-Surgical Therapies.

Background/objectives: Considering the antioxidant and antimicrobial properties attributed to compounds in extract, this research aimed to advance postoperative therapeutic innovations. Specifically, the study assessed the physicochemical properties of a film-forming solution (FFS) incorporated with , evaluating its therapeutic potential for postoperative applications.

Methods: The extract was meticulously characterized to determine its chemical composition, with particular emphasis on the concentration of phenolic compounds.

Nanostructured Glass-Ceramic Materials from Glass Waste with Antimicrobial Activity.

Modern consumption patterns have led to a surge in waste glass accumulating in municipal landfills, contributing to environmental pollution, especially in countries that do not have well-established recycling standards. While glass itself is 100% recyclable, the logistics and handling involved present significant challenges. Flint and amber-colored glass, often found in high quantities in municipal waste, can serve as valuable sources of raw materials.

Correlation between Genomic Variants and Worldwide COVID-19 Epidemiology.

COVID-19 is a systemic disease caused by the etiologic agent SARS-CoV-2, first reported in Hubei Province in Wuhan, China, in late 2019. The SARS-CoV-2 virus has evolved over time with distinct transmissibility subvariants from ancestral lineages. The clinical manifestations of the disease vary according to their severity and can range from asymptomatic to severe.